| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | supercoiled DNA binding | 9.53e-05 | 6 | 51 | 2 | GO:0097100 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 3.38e-04 | 130 | 51 | 4 | GO:0005200 | |
| GeneOntologyCellularComponent | cytoskeletal calyx | 1.75e-05 | 3 | 51 | 2 | GO:0033150 | |
| GeneOntologyCellularComponent | perinuclear theca | 5.81e-05 | 5 | 51 | 2 | GO:0033011 | |
| Domain | Cylicin_N | 6.74e-06 | 2 | 49 | 2 | IPR029354 | |
| Domain | CYLC | 6.74e-06 | 2 | 49 | 2 | IPR026189 | |
| Domain | Cylicin_N | 6.74e-06 | 2 | 49 | 2 | PF15241 | |
| Domain | SH3_9 | 5.17e-05 | 78 | 49 | 4 | PF14604 | |
| Domain | SH3_1 | 6.85e-05 | 164 | 49 | 5 | PF00018 | |
| Domain | SH3 | 2.49e-04 | 216 | 49 | 5 | SM00326 | |
| Domain | SH3 | 2.49e-04 | 216 | 49 | 5 | PS50002 | |
| Domain | SH3_domain | 2.71e-04 | 220 | 49 | 5 | IPR001452 | |
| Domain | I-BAR_dom | 5.16e-04 | 13 | 49 | 2 | IPR013606 | |
| Domain | FCH | 1.51e-03 | 22 | 49 | 2 | PF00611 | |
| Domain | FCH | 1.51e-03 | 22 | 49 | 2 | SM00055 | |
| Domain | FCH_dom | 1.65e-03 | 23 | 49 | 2 | IPR001060 | |
| Domain | F_BAR | 1.95e-03 | 25 | 49 | 2 | IPR031160 | |
| Domain | F_BAR | 1.95e-03 | 25 | 49 | 2 | PS51741 | |
| Domain | Ank_2 | 2.41e-03 | 215 | 49 | 4 | PF12796 | |
| Domain | Ank | 2.98e-03 | 228 | 49 | 4 | PF00023 | |
| Domain | PH | 3.03e-03 | 229 | 49 | 4 | PF00169 | |
| Domain | - | 4.02e-03 | 248 | 49 | 4 | 1.25.40.20 | |
| Domain | ANK | 4.20e-03 | 251 | 49 | 4 | SM00248 | |
| Domain | ANK_REPEAT | 4.32e-03 | 253 | 49 | 4 | PS50088 | |
| Domain | Ankyrin_rpt-contain_dom | 4.38e-03 | 254 | 49 | 4 | IPR020683 | |
| Domain | ANK_REP_REGION | 4.38e-03 | 254 | 49 | 4 | PS50297 | |
| Domain | Ankyrin_rpt | 4.89e-03 | 262 | 49 | 4 | IPR002110 | |
| Domain | PH | 6.02e-03 | 278 | 49 | 4 | SM00233 | |
| Domain | PH_DOMAIN | 6.09e-03 | 279 | 49 | 4 | PS50003 | |
| Domain | PH_domain | 6.17e-03 | 280 | 49 | 4 | IPR001849 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RBM25 PAXBP1 ARID4B UBN1 RBBP6 ZMAT2 SLTM ANKRD11 HMGB1 CCDC50 TOP1 HMGB1P1 HSP90AA1 DDX10 | 8.34e-11 | 954 | 52 | 14 | 36373674 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | HMGN5 RBM25 PAXBP1 ARID4B UBN1 RBBP6 MACO1 SLTM ANKRD11 HMGB1 INO80 TOP1 RPRD1B | 4.05e-08 | 1294 | 52 | 13 | 30804502 |
| Pubmed | 4.18e-07 | 191 | 52 | 6 | 20195357 | ||
| Pubmed | TRAF3 RBM25 ARID4B UBN1 RBBP6 ZFP91 HMGB1 INO80 TOP1 CNOT3 PACSIN2 DDX10 | 9.92e-07 | 1429 | 52 | 12 | 35140242 | |
| Pubmed | CYLC1 CYLC2 FAM114A1 ZMAT2 SEC62 HMGB1 CCDC50 POTEJ TOP1 HSP90AA1 CFAP46 MYBPC2 | 1.09e-06 | 1442 | 52 | 12 | 35575683 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.00e-06 | 774 | 52 | 9 | 15302935 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 28870917 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 38013430 | ||
| Pubmed | High Mobility Group Box-1 Protein and Interleukin 33 Expression in Allergic Rhinitis. | 2.19e-06 | 2 | 52 | 2 | 34979505 | |
| Pubmed | IL-33 and HMGB1 alarmins: sensors of cellular death and their involvement in liver pathology. | 2.19e-06 | 2 | 52 | 2 | 22530772 | |
| Pubmed | Cloning and analysis of a human 86-kDa heat-shock-protein-encoding gene. | 2.19e-06 | 2 | 52 | 2 | 2591742 | |
| Pubmed | HMGB1 regulates IL-33 expression in acute respiratory distress syndrome. | 2.19e-06 | 2 | 52 | 2 | 27318792 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 7737358 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 27868148 | ||
| Pubmed | Differential expression of IL-33 and HMGB1 in the lungs of stable cystic fibrosis patients. | 2.19e-06 | 2 | 52 | 2 | 24969657 | |
| Pubmed | IL-33 and HMGB1 modulate the progression of EAE via oppositely regulating each other. | 2.19e-06 | 2 | 52 | 2 | 37467690 | |
| Pubmed | RBM25 UBN1 RBBP6 ZFP91 SLTM HMGB1 INO80 TOP1 HSP90AA1 RPRD1B | 2.21e-06 | 1014 | 52 | 10 | 32416067 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 2.49e-06 | 588 | 52 | 8 | 38580884 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 20937816 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 38493291 | ||
| Pubmed | Targeting the P2Y13 Receptor Suppresses IL-33 and HMGB1 Release and Ameliorates Experimental Asthma. | 6.57e-06 | 3 | 52 | 2 | 34860143 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 15146192 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 33717650 | ||
| Pubmed | The Role of Alarmins in Osteoarthritis Pathogenesis: HMGB1, S100B and IL-33. | 6.57e-06 | 3 | 52 | 2 | 37569519 | |
| Pubmed | 7.74e-06 | 486 | 52 | 7 | 20936779 | ||
| Pubmed | HMGN5 ASAP2 RBM25 ARHGAP10 MACO1 ARHGAP26 HMGB1 CCDC50 PACSIN2 | 7.81e-06 | 916 | 52 | 9 | 32203420 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 9.13e-06 | 934 | 52 | 9 | 33916271 | |
| Pubmed | 1.01e-05 | 506 | 52 | 7 | 30890647 | ||
| Pubmed | PAXBP1 NEBL RBBP6 ARHGAP10 MACO1 ZFP91 ANKRD11 CCDC50 INO80 CNOT3 DDX10 | 1.07e-05 | 1497 | 52 | 11 | 31527615 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 1.14e-05 | 724 | 52 | 8 | 36232890 | |
| Pubmed | 1.22e-05 | 731 | 52 | 8 | 29298432 | ||
| Pubmed | The levels of retinoic acid-inducible gene I are regulated by heat shock protein 90-alpha. | 1.31e-05 | 4 | 52 | 2 | 19234166 | |
| Pubmed | Mapping of the gene family for human heat-shock protein 90 alpha to chromosomes 1, 4, 11, and 14. | 1.31e-05 | 4 | 52 | 2 | 1740332 | |
| Pubmed | 1.31e-05 | 4 | 52 | 2 | 23589305 | ||
| Pubmed | Unconventional Pathways of Secretion Contribute to Inflammation. | 1.31e-05 | 4 | 52 | 2 | 28067797 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.63e-05 | 361 | 52 | 6 | 26167880 | |
| Pubmed | TRAF3 RBBP6 SEC62 SLTM LAMB1 HMGB1 TOP1 CNOT3 HSP90AA1 RPRD1B | 1.91e-05 | 1297 | 52 | 10 | 33545068 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 2.48e-05 | 807 | 52 | 8 | 22681889 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 3.26e-05 | 608 | 52 | 7 | 36089195 | |
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 20731692 | ||
| Pubmed | 3.28e-05 | 6 | 52 | 2 | 11432776 | ||
| Pubmed | 3.49e-05 | 847 | 52 | 8 | 35850772 | ||
| Pubmed | 3.54e-05 | 123 | 52 | 4 | 35583604 | ||
| Pubmed | USP13 regulates HMGB1 stability and secretion through its deubiquitinase activity. | 4.58e-05 | 7 | 52 | 2 | 36585612 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 7.23e-05 | 289 | 52 | 5 | 23752268 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 7.52e-05 | 475 | 52 | 6 | 31040226 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | 7.75e-05 | 949 | 52 | 8 | 36574265 | |
| Pubmed | 7.84e-05 | 9 | 52 | 2 | 24257755 | ||
| Pubmed | GRAF2, WDR44, and MICAL1 mediate Rab8/10/11-dependent export of E-cadherin, MMP14, and CFTR ΔF508. | 7.84e-05 | 9 | 52 | 2 | 32344433 | |
| Pubmed | 7.84e-05 | 9 | 52 | 2 | 15184363 | ||
| Pubmed | The Endotoxin Delivery Protein HMGB1 Mediates Caspase-11-Dependent Lethality in Sepsis. | 7.84e-05 | 9 | 52 | 2 | 30314759 | |
| Pubmed | The E3 ubiquitin ligase Cul4b promotes CD4+ T cell expansion by aiding the repair of damaged DNA. | 7.84e-05 | 9 | 52 | 2 | 33524014 | |
| Pubmed | Jade-1S phosphorylation induced by CK1α contributes to cell cycle progression. | 8.26e-05 | 56 | 52 | 3 | 26919559 | |
| Pubmed | Mitochondrial phosphoproteome revealed by an improved IMAC method and MS/MS/MS. | 8.71e-05 | 57 | 52 | 3 | 17208939 | |
| Pubmed | 8.72e-05 | 1247 | 52 | 9 | 27684187 | ||
| Pubmed | 9.79e-05 | 10 | 52 | 2 | 24120361 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 1.33e-04 | 1318 | 52 | 9 | 30463901 | |
| Pubmed | 1.43e-04 | 12 | 52 | 2 | 11867214 | ||
| Pubmed | 1.48e-04 | 538 | 52 | 6 | 28524877 | ||
| Pubmed | 1.55e-04 | 340 | 52 | 5 | 29478914 | ||
| Pubmed | 1.62e-04 | 547 | 52 | 6 | 37267103 | ||
| Pubmed | 1.78e-04 | 1371 | 52 | 9 | 36244648 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 1.91e-04 | 1082 | 52 | 8 | 38697112 | |
| Pubmed | 1.93e-04 | 1084 | 52 | 8 | 11544199 | ||
| Pubmed | PRDM14 directly interacts with heat shock proteins HSP90α and glucose-regulated protein 78. | 1.97e-04 | 14 | 52 | 2 | 29178343 | |
| Pubmed | 2.36e-04 | 1116 | 52 | 8 | 31753913 | ||
| Pubmed | 2.57e-04 | 1440 | 52 | 9 | 30833792 | ||
| Pubmed | 2.59e-04 | 206 | 52 | 4 | 34185411 | ||
| Pubmed | The HSP90 family of genes in the human genome: insights into their divergence and evolution. | 2.60e-04 | 16 | 52 | 2 | 16269234 | |
| Pubmed | 3.25e-04 | 1487 | 52 | 9 | 33957083 | ||
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 3.60e-04 | 92 | 52 | 3 | 15840729 | |
| Pubmed | 4.19e-04 | 653 | 52 | 6 | 33742100 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | 4.26e-04 | 922 | 52 | 7 | 27609421 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 4.26e-04 | 235 | 52 | 4 | 30258100 | |
| Pubmed | 4.31e-04 | 425 | 52 | 5 | 24999758 | ||
| Pubmed | Identification of novel ARF binding proteins by two-hybrid screening. | 4.52e-04 | 21 | 52 | 2 | 16582619 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 5.10e-04 | 678 | 52 | 6 | 30209976 | |
| Pubmed | 5.16e-04 | 104 | 52 | 3 | 31365120 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 5.21e-04 | 1257 | 52 | 8 | 36526897 | |
| Pubmed | 5.46e-04 | 251 | 52 | 4 | 31076518 | ||
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 5.81e-04 | 695 | 52 | 6 | 23602568 | |
| Pubmed | 5.93e-04 | 24 | 52 | 2 | 27709293 | ||
| Pubmed | 6.73e-04 | 469 | 52 | 5 | 27634302 | ||
| Pubmed | Insights into the ubiquitin-proteasome system of human embryonic stem cells. | 7.08e-04 | 269 | 52 | 4 | 29511261 | |
| Pubmed | 7.38e-04 | 272 | 52 | 4 | 31010829 | ||
| Pubmed | 7.58e-04 | 274 | 52 | 4 | 34244482 | ||
| Pubmed | 8.65e-04 | 496 | 52 | 5 | 31343991 | ||
| Pubmed | 8.66e-04 | 284 | 52 | 4 | 29459677 | ||
| Pubmed | 9.12e-04 | 1049 | 52 | 7 | 27880917 | ||
| Pubmed | 9.29e-04 | 30 | 52 | 2 | 11483580 | ||
| Pubmed | 9.92e-04 | 31 | 52 | 2 | 25996949 | ||
| Pubmed | Genome-wide association study of periodontal pathogen colonization. | 9.92e-04 | 31 | 52 | 2 | 22699663 | |
| Pubmed | 9.92e-04 | 31 | 52 | 2 | 25817432 | ||
| Pubmed | E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis. | 1.10e-03 | 135 | 52 | 3 | 29859926 | |
| Pubmed | 1.12e-03 | 136 | 52 | 3 | 21280222 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | 1.22e-03 | 536 | 52 | 5 | 15840001 | |
| Pubmed | 1.24e-03 | 538 | 52 | 5 | 10512203 | ||
| Pubmed | DEPDC1B coordinates de-adhesion events and cell-cycle progression at mitosis. | 1.26e-03 | 35 | 52 | 2 | 25458010 | |
| Pubmed | 1.27e-03 | 142 | 52 | 3 | 30232004 | ||
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 1.28e-03 | 316 | 52 | 4 | 31665637 | |
| Interaction | SMC5 interactions | RBM25 PAXBP1 ARID4B UBN1 RBBP6 ZMAT2 SLTM ANKRD11 HMGB1 CCDC50 TOP1 HMGB1P1 HSP90AA1 DDX10 | 1.51e-07 | 1000 | 52 | 14 | int:SMC5 |
| Interaction | TERF2IP interactions | 1.05e-05 | 552 | 52 | 9 | int:TERF2IP | |
| Interaction | RALBP1 interactions | 1.17e-05 | 198 | 52 | 6 | int:RALBP1 | |
| Interaction | H2BC12 interactions | 1.80e-05 | 322 | 52 | 7 | int:H2BC12 | |
| Interaction | TERF2 interactions | 2.55e-05 | 340 | 52 | 7 | int:TERF2 | |
| Interaction | DDX23 interactions | 2.93e-05 | 480 | 52 | 8 | int:DDX23 | |
| Interaction | TRIM37 interactions | 2.98e-05 | 630 | 52 | 9 | int:TRIM37 | |
| Interaction | POLR1G interactions | 3.34e-05 | 489 | 52 | 8 | int:POLR1G | |
| Interaction | DHX40 interactions | 4.24e-05 | 249 | 52 | 6 | int:DHX40 | |
| Interaction | ZBTB49 interactions | 5.65e-05 | 29 | 52 | 3 | int:ZBTB49 | |
| Interaction | SSRP1 interactions | 5.71e-05 | 685 | 52 | 9 | int:SSRP1 | |
| Interaction | H2BC21 interactions | 6.46e-05 | 696 | 52 | 9 | int:H2BC21 | |
| Interaction | H3C1 interactions | CYLC2 HMGN5 ARID4B UBN1 ARHGAP10 ZMAT2 ZFP91 HMGB1 TOP1 DDX10 | 8.69e-05 | 901 | 52 | 10 | int:H3C1 |
| Interaction | IKZF1 interactions | 9.48e-05 | 288 | 52 | 6 | int:IKZF1 | |
| Interaction | ACTL6A interactions | 9.66e-05 | 289 | 52 | 6 | int:ACTL6A | |
| Interaction | POLR2E interactions | 1.37e-04 | 308 | 52 | 6 | int:POLR2E | |
| Interaction | ZNF330 interactions | 1.40e-04 | 446 | 52 | 7 | int:ZNF330 | |
| Interaction | PLG interactions | 1.61e-04 | 106 | 52 | 4 | int:PLG | |
| Interaction | NAA40 interactions | HMGN5 NEBL RBBP6 ZMAT2 CCDC50 CGNL1 USP16 TOP1 HSP90AA1 DDX10 | 1.70e-04 | 978 | 52 | 10 | int:NAA40 |
| Interaction | EP300 interactions | NUTM1 RBM25 UBN1 RBBP6 SEC62 ZFP91 SLTM HMGB1 CNOT3 HMGB1P1 RPRD1B HSP90AA2P | 1.85e-04 | 1401 | 52 | 12 | int:EP300 |
| Interaction | SNRPA interactions | 2.26e-04 | 482 | 52 | 7 | int:SNRPA | |
| Interaction | TNIP1 interactions | HMGN5 TRAF3 RBM25 RBBP6 ZMAT2 ZFP91 SLTM TOP1 HSP90AA1 HSP90AA2P DDX10 | 2.27e-04 | 1217 | 52 | 11 | int:TNIP1 |
| Interaction | TAX1BP1 interactions | 2.41e-04 | 342 | 52 | 6 | int:TAX1BP1 | |
| Cytoband | 15q22.1 | 2.63e-05 | 7 | 52 | 2 | 15q22.1 | |
| GeneFamily | Canonical high mobility group | 2.10e-04 | 11 | 36 | 2 | 511 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 9.50e-04 | 23 | 36 | 2 | 1288 | |
| GeneFamily | Ankyrin repeat domain containing | 1.32e-03 | 242 | 36 | 4 | 403 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 4.45e-03 | 50 | 36 | 2 | 721 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 1.57e-06 | 417 | 52 | 8 | M39224 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 1.85e-06 | 295 | 52 | 7 | M39121 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 1.02e-05 | 68 | 52 | 4 | M1373 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 1.28e-05 | 72 | 52 | 4 | MM1131 | |
| Coexpression | BASAKI_YBX1_TARGETS_DN | 1.31e-05 | 398 | 52 | 7 | M14877 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 2.67e-05 | 177 | 52 | 5 | M39245 | |
| Coexpression | BUSSLINGER_GASTRIC_ISTHMUS_CELLS | 3.22e-05 | 458 | 52 | 7 | M40010 | |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 5.50e-05 | 206 | 52 | 5 | M39254 | |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | 1.45e-04 | 404 | 52 | 6 | M19488 | |
| Coexpression | MARTIN_VIRAL_GPCR_SIGNALING_DN | 1.52e-04 | 52 | 52 | 3 | M1330 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 6.82e-06 | 298 | 51 | 7 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.48e-05 | 469 | 51 | 8 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | HMGN5 TCEA3 RBM25 ARID4B SLCO1A2 ARHGAP26 SLTM CCDC50 CGNL1 TOP1 IL33 | 1.65e-05 | 979 | 51 | 11 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | 1.28e-04 | 819 | 51 | 9 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-09 | 187 | 51 | 7 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 2.93e-09 | 199 | 51 | 7 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 3.03e-09 | 200 | 51 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-08 | 188 | 51 | 6 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.11e-08 | 194 | 51 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 9.98e-08 | 197 | 51 | 6 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 9.98e-08 | 197 | 51 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 1.03e-07 | 198 | 51 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.03e-07 | 198 | 51 | 6 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.03e-07 | 198 | 51 | 6 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.06e-07 | 199 | 51 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 1.06e-07 | 199 | 51 | 6 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 2.43e-06 | 188 | 51 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 3.21e-06 | 199 | 51 | 5 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 3.21e-06 | 199 | 51 | 5 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 3.21e-06 | 199 | 51 | 5 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.28e-06 | 200 | 51 | 5 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.89e-05 | 138 | 51 | 4 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.90e-05 | 176 | 51 | 4 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.46e-05 | 181 | 51 | 4 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 5.82e-05 | 184 | 51 | 4 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-05 | 186 | 51 | 4 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-05 | 186 | 51 | 4 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 6.87e-05 | 192 | 51 | 4 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 6.87e-05 | 192 | 51 | 4 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 7.01e-05 | 193 | 51 | 4 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | PND01|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.01e-05 | 193 | 51 | 4 | c291345c11cfcbceacbdc001a5851f67478a2779 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.29e-05 | 195 | 51 | 4 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | COVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters | 7.44e-05 | 196 | 51 | 4 | ad43efdd4d73b6615f65f06a315b33576e317473 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Secretory|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.44e-05 | 196 | 51 | 4 | 47930de6b47b7bf22d8dae8b7419a9cd1d22f0ea | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.58e-05 | 197 | 51 | 4 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | COVID-19_Mild-PLT_4|COVID-19_Mild / Disease Group and Platelet Clusters | 7.73e-05 | 198 | 51 | 4 | 3d8c33dba759df0974aeb2b9a6b5167ae7a18e1f | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 7.89e-05 | 199 | 51 | 4 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 8.04e-05 | 200 | 51 | 4 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.04e-05 | 200 | 51 | 4 | ed093626a9cac7531a2bf02f6e345c5e84b8c060 | |
| Drug | 2qfo | 5.12e-06 | 2 | 52 | 2 | CID000600769 | |
| Drug | 3-amino-5-chlorobenzoic acid | 5.12e-06 | 2 | 52 | 2 | CID010986726 | |
| Drug | 3eko | 5.12e-06 | 2 | 52 | 2 | CID011160307 | |
| Drug | monocillin III | 5.12e-06 | 2 | 52 | 2 | CID006478910 | |
| Drug | pochonin A | 5.12e-06 | 2 | 52 | 2 | CID006478909 | |
| Drug | 1uyi | 5.12e-06 | 2 | 52 | 2 | CID005289232 | |
| Drug | PU-H71 | 5.12e-06 | 2 | 52 | 2 | CID009549213 | |
| Drug | NSC683666 | 5.12e-06 | 2 | 52 | 2 | CID005469153 | |
| Drug | H 64 | 5.12e-06 | 2 | 52 | 2 | CID006914564 | |
| Drug | SureCN4151355 | 5.12e-06 | 2 | 52 | 2 | CID015942101 | |
| Drug | 1uyc | 5.12e-06 | 2 | 52 | 2 | CID000448969 | |
| Drug | PU-9 | 5.12e-06 | 2 | 52 | 2 | CID000448971 | |
| Drug | P u 0 | 5.12e-06 | 2 | 52 | 2 | CID000448974 | |
| Drug | 2qf6 | 5.12e-06 | 2 | 52 | 2 | CID013373715 | |
| Drug | CHEBI:42139 | 5.12e-06 | 2 | 52 | 2 | CID011562562 | |
| Drug | wedelolactone | 1.25e-05 | 20 | 52 | 3 | CID005281813 | |
| Drug | pochonin D | 1.53e-05 | 3 | 52 | 2 | CID006478913 | |
| Drug | azaquinone | 1.53e-05 | 3 | 52 | 2 | CID000099132 | |
| Drug | d 1 v | 1.53e-05 | 3 | 52 | 2 | CID000683940 | |
| Drug | HM-9 | 1.53e-05 | 3 | 52 | 2 | CID000433437 | |
| Drug | Glyoxylspermidine | 1.53e-05 | 3 | 52 | 2 | CID000133564 | |
| Drug | AC1MD0RC | 1.53e-05 | 3 | 52 | 2 | CID002829073 | |
| Drug | uranyl chloride | 3.06e-05 | 4 | 52 | 2 | CID000082259 | |
| Drug | methoxyhydroquinone | 3.06e-05 | 4 | 52 | 2 | CID000069988 | |
| Drug | 11p110 | 3.06e-05 | 4 | 52 | 2 | CID002382787 | |
| Drug | 1uy7 | 5.09e-05 | 5 | 52 | 2 | CID005289227 | |
| Drug | 1uyd | 5.09e-05 | 5 | 52 | 2 | CID000448970 | |
| Drug | Org 31806 | 5.09e-05 | 5 | 52 | 2 | CID000164147 | |
| Drug | CRT0044876 | 5.09e-05 | 5 | 52 | 2 | CID000081409 | |
| Drug | HCV-796 | 5.09e-05 | 5 | 52 | 2 | CID011561383 | |
| Drug | chaetochromin | 5.09e-05 | 5 | 52 | 2 | CID000053277 | |
| Drug | 1,1-diphenyl-2-propyn-1-ol | 5.09e-05 | 5 | 52 | 2 | CID000092976 | |
| Drug | Pinacidil [85371-64-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A | 7.44e-05 | 191 | 52 | 5 | 5456_DN | |
| Drug | Hantzsch ester | 7.63e-05 | 6 | 52 | 2 | CID000070849 | |
| Drug | 3-aminocoumarin | 7.63e-05 | 6 | 52 | 2 | CID000074217 | |
| Drug | Pu x | 7.63e-05 | 6 | 52 | 2 | CID000448976 | |
| Drug | chromomycin A3 | 9.05e-05 | 103 | 52 | 4 | CID000656673 | |
| Drug | 17-aminogeldanamycin | 1.07e-04 | 7 | 52 | 2 | CID000429444 | |
| Drug | Nepl | 1.07e-04 | 7 | 52 | 2 | CID006439214 | |
| Drug | NSC330499 | 1.07e-04 | 7 | 52 | 2 | CID000433447 | |
| Drug | 1,2,4,7,8-pentachlorodibenzo-p-dioxin | 1.07e-04 | 7 | 52 | 2 | CID000042836 | |
| Drug | Zlll-mca | 1.07e-04 | 7 | 52 | 2 | CID000132936 | |
| Drug | dienochlor | 1.07e-04 | 7 | 52 | 2 | CID000016686 | |
| Drug | phenyldichloroarsine | 1.42e-04 | 8 | 52 | 2 | CID000012762 | |
| Drug | GGMP | 1.42e-04 | 8 | 52 | 2 | CID006443839 | |
| Drug | D-box | 1.42e-04 | 8 | 52 | 2 | CID000133881 | |
| Drug | 9-phenanthrol | 1.42e-04 | 8 | 52 | 2 | CID000010229 | |
| Drug | 5,8-quinolinedione | 1.82e-04 | 9 | 52 | 2 | CID000388306 | |
| Drug | antheridiol | 1.82e-04 | 9 | 52 | 2 | CID000159927 | |
| Drug | JJ3 | 1.82e-04 | 9 | 52 | 2 | CID009927355 | |
| Drug | boceprevir | 1.82e-04 | 9 | 52 | 2 | CID010324367 | |
| Drug | nibentan | 1.82e-04 | 9 | 52 | 2 | CID000177905 | |
| Drug | noviose | 1.82e-04 | 9 | 52 | 2 | CID005461025 | |
| Drug | AC1NUZLU | 1.93e-04 | 234 | 52 | 5 | CID005497170 | |
| Drug | ORG 2058 | 2.17e-04 | 51 | 52 | 3 | CID000119086 | |
| Drug | n-C6 | 2.28e-04 | 10 | 52 | 2 | CID006420120 | |
| Drug | PU-6 | 2.28e-04 | 10 | 52 | 2 | CID000448968 | |
| Drug | formetanate | 2.28e-04 | 10 | 52 | 2 | CID000031099 | |
| Drug | AC1L44ZM | 2.28e-04 | 10 | 52 | 2 | CID000200744 | |
| Drug | PCI 5002 | 2.43e-04 | 735 | 52 | 8 | ctd:C568608 | |
| Drug | AC1L4LMA | 2.57e-04 | 54 | 52 | 3 | CID000208924 | |
| Drug | Pu-3 | 2.78e-04 | 11 | 52 | 2 | CID000448965 | |
| Drug | AC1L9ICX | 2.78e-04 | 11 | 52 | 2 | CID000445664 | |
| Drug | I-hu | 2.78e-04 | 11 | 52 | 2 | CID009547901 | |
| Drug | VER-49009 | 2.78e-04 | 11 | 52 | 2 | CID005327095 | |
| Drug | 2ohu | 3.33e-04 | 12 | 52 | 2 | CID011633167 | |
| Drug | 4-oxo-2-nonenal | 3.33e-04 | 12 | 52 | 2 | CID006445537 | |
| Drug | AHBA | 3.93e-04 | 13 | 52 | 2 | CID000127115 | |
| Drug | AC1L85F0 | 3.93e-04 | 13 | 52 | 2 | CID000372766 | |
| Drug | steroid D | 3.93e-04 | 13 | 52 | 2 | CID000454475 | |
| Drug | CMV423 | 3.93e-04 | 13 | 52 | 2 | CID000489128 | |
| Drug | TNP-GTP | 3.93e-04 | 13 | 52 | 2 | CID000126171 | |
| Drug | NSC 255110 | 3.93e-04 | 13 | 52 | 2 | CID000318505 | |
| Drug | AC1L3HJJ | 3.93e-04 | 13 | 52 | 2 | CID000089287 | |
| Drug | FLT3 inhibitor | 4.57e-04 | 14 | 52 | 2 | CID001048845 | |
| Drug | FG 1 | 4.57e-04 | 14 | 52 | 2 | CID005288213 | |
| Disease | serum gamma-glutamyl transferase measurement | TRAF3 RBM25 ARHGAP10 SLCO1A2 ZFP91 PSD3 HMGB1 CCDC50 CGNL1 USP16 TOP1 | 2.36e-07 | 914 | 49 | 11 | EFO_0004532 |
| Disease | X-linked mental retardation with cerebellar hypoplasia and distinctive facial appearance (implicated_via_orthology) | 1.62e-05 | 4 | 49 | 2 | DOID:0080311 (implicated_via_orthology) | |
| Disease | pulse pressure measurement | 4.20e-04 | 1392 | 49 | 9 | EFO_0005763 | |
| Disease | cortex volume change measurement, age at assessment | 9.93e-04 | 28 | 49 | 2 | EFO_0008007, EFO_0021500 | |
| Disease | cancer (implicated_via_orthology) | 1.02e-03 | 268 | 49 | 4 | DOID:162 (implicated_via_orthology) | |
| Disease | chronic rhinosinusitis | 1.46e-03 | 34 | 49 | 2 | EFO_1000024 | |
| Disease | QRS duration | 1.51e-03 | 298 | 49 | 4 | EFO_0005055 | |
| Disease | grey matter volume measurement | 2.44e-03 | 44 | 49 | 2 | EFO_0005420 | |
| Disease | caudate nucleus measurement, functional brain measurement, response to reward | 2.78e-03 | 47 | 49 | 2 | EFO_0007849, EFO_0008387, EFO_0008396 | |
| Disease | atrial fibrillation | 3.34e-03 | 371 | 49 | 4 | EFO_0000275 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IKNKLDKEKDKDEKY | 641 | Q4LE39 | |
| KISKEKEKIFKEDKE | 786 | Q6UB99 | |
| KEDKEKLKKEKVYRE | 796 | Q6UB99 | |
| KEKKDKESTEKYKDR | 1206 | Q6UB99 | |
| AKKEKAEKKEKGEDY | 1366 | Q6UB99 | |
| AEEKKAYKKAKEREK | 211 | Q8IVM0 | |
| SKEKDKEKGKEEKVK | 1386 | Q8IYW2 | |
| SKKGKDIEKGKEEKL | 141 | Q14093 | |
| NDGKEKYEKEKIKSI | 156 | Q4L235 | |
| EKEKHKKEIEGEKEK | 661 | Q6UB98 | |
| KKEIEGEKEKYKTKD | 666 | Q6UB98 | |
| GEKEKYKTKDSAKEL | 671 | Q6UB98 | |
| KEKYEADLKKEIKKL | 41 | O75175 | |
| KEIAKKKNDKKEAYV | 276 | Q09MP3 | |
| DTHKKLEEEKGKKEK | 286 | P49756 | |
| REKYAEKKKKEDELD | 1301 | Q9ULG1 | |
| AVKEEKKKFDKETEK | 126 | A1A4S6 | |
| SKDEVKAYLKKEFEK | 156 | Q9NWM8 | |
| KKAAKLKEKYEKDIA | 146 | P09429 | |
| KDYETKITKIEKEKK | 151 | O43150 | |
| DIKKVKEEKAYKALK | 226 | P83111 | |
| EYREKGKEKDKDAKK | 251 | Q8N5G2 | |
| KDDKKKDTKKYPEST | 356 | P35663 | |
| EKGDKKEGKDVKVKE | 216 | P82970 | |
| VKKTLDGELDEKYKK | 1686 | P07942 | |
| KKEYKEDLEKSKIKT | 136 | Q9Y5B6 | |
| KEEKVKKDYSKDVKS | 1106 | Q7Z6E9 | |
| KGKEKKKKEAEEEDE | 1001 | Q86Y26 | |
| KCKQDVLKTKEKYEK | 196 | Q9UNF0 | |
| YVEDLKKDEKKDKVL | 146 | O95760 | |
| KEEEKKKYYDTKIED | 96 | P51878 | |
| KGDEAKAKETLKKYE | 856 | Q0VF96 | |
| KEKYKEALAKGKETE | 151 | P16591 | |
| EMKIKEEGYKKEISK | 121 | Q4G0S7 | |
| EEDKFDKEEYRKKIK | 731 | Q13206 | |
| KKKKIKEKYIDQEEL | 276 | P07900 | |
| DGDKKKKKTKEKYID | 271 | Q14568 | |
| EEKEKKKKKKGTAEE | 1301 | Q9HC10 | |
| KKEEKKTKTIEEVYM | 431 | Q8IWE2 | |
| KDVLSEKEKKLEEYK | 266 | Q9NQG5 | |
| KKAAKLKEKYEKDIA | 146 | B2RPK0 | |
| AAKEAKKKYDKETEK | 126 | Q9UNA1 | |
| KKKYLEDIESVKKKN | 636 | P0CG39 | |
| EKKESKDTKKIEGKD | 511 | Q9NWH9 | |
| KEEVKKEKYGITKDF | 291 | P46721 | |
| VKKKHKDTEYKKTDI | 496 | O14967 | |
| EKFVKTVEDKYKCEK | 41 | Q13114 | |
| EELKNKVKDYEKKKS | 336 | Q9Y5T5 | |
| KYDKDIKKEKDKGKA | 101 | Q99442 | |
| KKKDGEKEESKKEET | 141 | Q99442 | |
| KGEKGEEREKAKKKE | 86 | O75764 | |
| GGEKIKKKKKDDTYD | 196 | Q9NPG3 | |
| GKVKEEKEKKEIKVE | 251 | Q96JP5 | |
| DKKVKAKDVDEYKLK | 956 | Q9NYI0 | |
| DYKPKKIKTEDTKKE | 146 | P11387 | |
| EEEEKAKAYKKEKQK | 151 | Q96NC0 | |
| EEKKKKKKDDDDLGI | 196 | Q14324 | |
| EKEYKKDLESIIKGK | 446 | O76041 |